Showing 1 - 10 of 23
A bill to consolidate and amend the law relating to the scientific development and regulation of mines and minerals under the control of the Union. URL:[http://pib.nic.in/archieve/others/2011/sep/d2011093002.pdf].
Persistent link: https://www.econbiz.de/10009323711
The Chin State of Burma (also known as Myanmar) is an isolated ethnic minority area with poor health outcomes and reports of food insecurity and human rights violations. A report on a population-based assessment of health and human rights in Chin State is given. It is sought to quantify reported...
Persistent link: https://www.econbiz.de/10009002284
THE DRUGS AND COSMETICS (AMENDMENT) BILL, 2005 A Bill further to amend the Drugs and Cosmetics Act, 1940. Under examination with the Committee on Health and Family Welfare On adulterated and spurious drugs
Persistent link: https://www.econbiz.de/10005528115
The Task Force recommends that price regulation should be on the basis of ‘Essentiality’ of the drug and it should be applied only to formulations and not to upstream products, such as bulk drugs. No effort should be made to impose a uniform price, and only a ceiling price should be...
Persistent link: https://www.econbiz.de/10005528148
product patents for pharmaceuticals, this paper provides a rigorously-derived estimate of the possible impact of …-bacterials (i.e., antibiotics) in the Indian pharmaceuticals market. These estimates are then used to carry out counterfactual …
Persistent link: https://www.econbiz.de/10005528220
examination for pharmaceuticals inventions, particularly in developing countries. It proposes a set of general guidelines for the …
Persistent link: https://www.econbiz.de/10005528232
This report analyzes the ITRIPS agreement. It discuses the problems and stakes, and consequences of this agreement. The report also provides case studies related to the topic and finally gives a suggestive conclusion.
Persistent link: https://www.econbiz.de/10005528311
While welcoming the move to withdraw the Report of the Technical Expert Group on Patent Law Issues AIDAN has issued a statement that the group must not be allowed to re-submit the report. The matter must be referred to a Parliamentary Standing Committee.
Persistent link: https://www.econbiz.de/10005528317
Rising drug prices and misuse of drugs: Calling Attention
Persistent link: https://www.econbiz.de/10005487581
Pharmaceuticals Policy, 2005 has been necessitated due to several developments that have taken place during the course of last few … several other matters having a close bearing on the pharmaceuticals sector have also been included in the policy. …
Persistent link: https://www.econbiz.de/10005487771